Search results
Results From The WOW.Com Content Network
This article provides a list of autoimmune diseases. These conditions, where the body's immune system mistakenly attacks its own cells, affect a range of organs and systems within the body. Each disorder is listed with the primary organ or body part that it affects and the associated autoantibodies that are typically found in people diagnosed ...
This list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not necessarily indicate clinical usage. See the list of FDA-approved therapeutic monoclonal antibodies in the monoclonal antibody therapy page.
Treatment of autoimmune disease can be broadly classified into anti-inflammatory, immunosuppressive, and palliative – i.e., correcting a functional disturbance related to the condition. [8] Some medications used to treat autoimmune diseases might not be safe to use during pregnancy. [2] [8]
The immune system of the human body is different in the body of a pregnant person, compared to any other human being. Pregnant people are more susceptible to disease, and the idea of even treating these diseases can be risky. Complications caused by treating these diseases can lead to long term damage to the parent, fetus, or both.
In the case of an autoimmune-induced miscarriage, the woman's body attacks the growing fetus or prevents normal pregnancy progression. [9] [94] Autoimmune disease may cause abnormalities in embryos, which in turn may lead to miscarriage. As an example, coeliac disease increases the risk of miscarriage by an odds ratio of approximately 1.4.
Monoclonal antibody therapy may prove to be beneficial for cancer, autoimmune diseases, and neurological disorders that result in the degeneration of body cells, such as Alzheimer's disease. Monoclonal antibody therapy can aid the immune system because the innate immune system responds to the environmental factors it encounters by ...
This month, the FDA granted accelerated approval to Iqirvo (elafibranor) for the treatment of an autoimmune disease that can affect the liver called primary biliary cholangitis. FDA Approves Drug ...
Lymphoma and a variety of autoimmune diseases, although it may be ineffective in treating IgA-mediated diseases. [ 13 ] Cardiac arrest , cytokine release syndrome , tumor lysis syndrome and acute kidney injury , infections, [ 14 ] hepatitis B reactivation, immune toxicity, pulmonary toxicity, [ 15 ] bowel obstruction and perforation [ 16 ] [ 17 ...